Outlook Therapeutics
OTLK
OTLK
75 hedge funds and large institutions have $25.3M invested in Outlook Therapeutics in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 24 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
44% less capital invested
Capital invested by funds: $45.3M → $25.3M (-$20.1M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
75
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$281K | |
| 2 | +$227K | |
| 3 | +$197K | |
| 4 |
LPL Financial
San Diego,
California
|
+$51.5K |
| 5 |
LNC
Lincoln National Corp
Radnor,
Pennsylvania
|
+$50.9K |
Top Sellers
| 1 | -$529K | |
| 2 | -$420K | |
| 3 | -$195K | |
| 4 |
Jane Street
New York
|
-$145K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$120K |